has been cited by the following article(s):
|
[1]
|
Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy
International Immunopharmacology,
2019
DOI:10.1016/j.intimp.2019.105785
|
|
|
|
|
[2]
|
Developmental Toxicity of Zinc Oxide Nanoparticles to Zebrafish (Danio rerio): A Transcriptomic Analysis
PLOS ONE,
2016
DOI:10.1371/journal.pone.0160763
|
|
|
|
|
[3]
|
Lipid-Conjugation of Endogenous Neuropeptides: Improved Biotherapy against Human Pancreatic Cancer
Advanced Healthcare Materials,
2015
DOI:10.1002/adhm.201400816
|
|
|
|
|
[4]
|
Opioid growth factor receptor (OGFR) expression is downregulated with progression of triple negative breast cancer
International Journal of Cancer Therapy and Oncology,
2015
DOI:10.14319/ijcto.34.7
|
|
|
|
|
[5]
|
Novel treatment for triple-negative breast and ovarian cancer: endogenous opioid suppression of women's cancers
Expert Review of Anticancer Therapy,
2014
DOI:10.1586/14737140.2014.867234
|
|
|
|
|
[6]
|
Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer
Experimental Biology and Medicine,
2013
DOI:10.1177/1535370213488483
|
|
|
|
|
[7]
|
Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer
Experimental Biology and Medicine,
2012
DOI:10.1258/ebm.2011.011321
|
|
|
|
|
[8]
|
Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology,
2012
DOI:10.1152/ajpregu.00670.2011
|
|
|
|
|
[9]
|
The opioid growth factor–opioid growth factor receptor axis: Homeostatic regulator of cell proliferation and its implications for health and disease
Biochemical Pharmacology,
2012
DOI:10.1016/j.bcp.2012.05.018
|
|
|
|